
What We’re Reading: Manchin Backs Inflation Deal; AbbVie’s $2 Billion Opioid Settlement; Vitamin D Pills and Fractures
Senator Joe Manchin, D-West Virginia, ended his opposition to the Inflation Reduction Act of 2022, paving the way for reductions in some Affordable Care Act subsidies and action on drug pricing; AbbVie’s Allergan agreed to pay more than $2 billion in opioid settlements; a study found vitamin D supplements do not reduce bone fracture risk.
Manchin Agrees on Inflation Reduction Act
Senators Joe Manchin, D-West Virginia, and Chuck Schumer, D-New York, agreed to a deal supporting the Biden administration’s legislative package that would spend $433 billion towards health care, prescription drug, climate, and tax policies and programs.
AbbVie’s Allergan Unit Agrees to $2 Billion Opioid Settlement
AbbVie’s Allergan agreed to pay more than $2 billion to settle more than 3000 lawsuits related to the marketing of Allergan’s opioid painkiller, Kadian,
Vitamin D Pills Have No Effect on Bone Fracture Risk
Despite the widely-accepted idea that vitamin D pills can protect bones from fractures, a study published in
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.